Cyclophosphamide, 2,2-dimethylaziridines and other alkylating agents as inhibitors of serum cholinesterase
- 15 February 1975
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 24 (4) , 455-462
- https://doi.org/10.1016/0006-2952(75)90128-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Reactions of 2,2-dimethylaziridine-type Alkylating Agents in Biological Systems I: Colorimetric Estimation and Stability in Physiological MediaJournal of Pharmaceutical Sciences, 1973
- Cyclophosphamide, Cholinesterase and Anaesthesia*Australian and New Zealand Journal of Medicine, 1972
- The effect of a series of anti-cancer drugs on plasma cholinesterase activityCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1972
- STRUCTURE-ACTIVITY RELATIONSHIPS OF ALKYLATING AGENTS IN CANCER CHEMOTHERAPYAnnals of the New York Academy of Sciences, 1969
- Die Hemmung der Serumcholinesterase durch Cyclophosphamid (Endoxan®)Klinische Wochenschrift, 1965
- Synthesis of Potential Dual Antagonists IV.Journal of Pharmaceutical Sciences, 1965
- Studies on the mechanism of action of cyclophosphamide and AB-132 with the aid of radioprotective agentsLife Sciences, 1964
- Affinity and Phosphorylation Constants for the Inhibition of Esterases by OrganophosphatesScience, 1964
- Prolonged Apnea Following Succinylcholine in Cancer Patients Receiving AB-132Anesthesiology, 1963
- Consideration of chemical reaction mechanisms in relationship to the biological action of “dual antagonists”Biochemical Pharmacology, 1962